FDA Inspection 1264966 — Caribou Biosciences, Inc.

Caribou Biosciences, Inc. — FEI 3033656198

The FDA completed an inspection of Caribou Biosciences, Inc. on Mar 21, 2025 in Berkeley, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 21, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Berkeley, CA (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.